CD49D AND CD26 ARE INDEPENDENT PROGNOSTIC MARKERS FOR DISEASE PROGRESSION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Ibrahim, L. [1 ]
机构：
[1] Mansoura Fac Med Egypt, Clin Pathol & Haematol, Abu Dhabi, U Arab Emirates
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1785
引用
收藏
页码：722 / 722
页数：1
相关论文
共 50 条
  • [21] CD49d, Zap-70, and CD38 Expression in Chronic Lymphocytic Leukemia
    Singleterry, Will L.
    Cruse, Julius M.
    Lewis, Robert E.
    Coker, John A.
    Suggs, Jeanann L.
    FASEB JOURNAL, 2009, 23
  • [22] CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential
    Shanafelt, Tait D.
    Geyer, Susan M.
    Bone, Nancy D.
    Tschumper, Renee C.
    Witzig, Tom E.
    Nowakowski, Greg S.
    Zent, Clive S.
    Call, Tim G.
    LaPlant, Betsy
    Dewald, Gordon W.
    Jelinek, Diane F.
    Kay, Neil E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 140 (05) : 537 - 546
  • [23] Molecular Profiling Identifies CD49d and CD79b as Predictive Markers for Acquired Acalabrutinib Resistance in Patients With Chronic Lymphocytic Leukemia
    Bibikova, Elena
    Parsa, Sara
    Floren, Muskan
    Law, Brian
    Clevenger, Tracy
    Cheung, Jean
    De Jesus, Gary
    Burke, Kathleen
    Gulrajani, Michael
    Yamaguchi, Kyoko
    Do, Phuong
    Dougherty, Brian
    Whitston, David
    Brock, Graham
    Munugalavadla, Veerendra
    Frigault, Melanie M.
    Hartmann, Tanja N.
    Byrd, John C.
    Furman, Richard R.
    Brown, Jennifer R.
    Covey, Todd
    Mortlock, Andrew
    HEMATOLOGICAL ONCOLOGY, 2025, 43 (01)
  • [24] CD49d Prevails over the Novel Recurrent Mutations As Independent Prognosticator of Overall Survival in Chronic Lymphocytic Leukemia
    Dal Bo, Michele
    Bulian, Pietro
    Bomben, Riccardo
    Zucchetto, Antonella
    Rossi, Francesca
    Pozzo, Federico
    Bittolo, Tamara
    Nanni, Paola
    Cattarossi, Ilaria
    Zaina, Eva
    Chivilo, Hillarj
    Degan, Massimo
    Zaja, Francesco
    Pozzato, Gabriele
    Chiarenza, Annalisa
    Di Raimondo, Francesco
    Del Poeta, Giovanni
    Rossi, Davide
    Gaidano, Gianluca
    Gattei, Valter
    BLOOD, 2015, 126 (23)
  • [25] CD49d is an independent prognostic marker for time to first treatment and overall survival in chronic lymphocytic leukaemia (CLL)
    Majid, A.
    Lin, T.
    Best, G.
    Hewamana, S.
    Pratt, G.
    Wagner, S.
    Kennedy, D. B.
    Miall, F.
    Brennan, P.
    Oscier, D. G.
    Dyer, M. J. S.
    Fegan, C.
    Pepper, C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 92 - 92
  • [26] CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia
    M Dal Bo
    P Bulian
    R Bomben
    A Zucchetto
    F M Rossi
    F Pozzo
    E Tissino
    D Benedetti
    T Bittolo
    P Nanni
    I Cattarossi
    E Zaina
    H Chivilò
    M Degan
    F Zaja
    G Pozzato
    A Chiarenza
    F Di Raimondo
    M I Del Principe
    G Del Poeta
    D Rossi
    G Gaidano
    V Gattei
    Leukemia, 2016, 30 : 2011 - 2018
  • [27] CD49D EXPRESSION AND SHORT TELOMERE LENGTH INTERACT IN CHRONIC LYMPHOCYTIC LEUKEMIA AND IDENTIFY PATIENTS AT RISK OF PROGRESSION AND SHORT SURVIVAL
    Rossi, D.
    Ladetto, M.
    Bodoni, C. Lobetti
    Zucchetto, A.
    Rossi, F. M.
    Gattei, V.
    Gaidano, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 142 - 143
  • [28] Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia
    Gattei, Valter
    Bulian, Pietro
    Del Principe, Maria Ilaria
    Zucchetto, Antonella
    Maurillo, Luca
    Buccisano, Francesco
    Bomben, Riccardo
    Dal-Bo, Michele
    Luciano, Fabrizio
    Rossi, Francesca M.
    Degan, Massimo
    Amadori, Sergio
    Del Poeta, Giovanni
    BLOOD, 2008, 111 (02) : 865 - 873
  • [29] High CD49d protein expression predicts short overall survival and early progression in chronic lymphocytic leukemia patients.
    Gattei, Valter
    Bulian, Pietro
    Del-Principe, Maria Ilaria
    Zucchetto, Antonella
    Maurillo, Luca
    Buccisano, Francesco
    Bomben, Riccardo
    Dal-Bo, Michele
    Luciano, Fabrizio
    Rossi, Francesca M.
    Degan, Massimo
    Amadori, Sergio
    Del-Poeta, Giovanni
    BLOOD, 2007, 110 (11) : 911A - 911A
  • [30] Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages
    EksiogluDemiralp, E
    Alpdogan, O
    Aktan, M
    Firatli, T
    Ozturk, A
    Budak, T
    Bayik, M
    Akoglu, T
    LEUKEMIA, 1996, 10 (08) : 1331 - 1339
12345